Novo A/S
Latest statistics and disclosures from Novo Holdings A/S's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VTI, TEM, BN, EWTX, CORT, and represent 48.17% of Novo Holdings A/S's stock portfolio.
- Added to shares of these 8 stocks: Zenas Biopharma (+$20M), VRDN (+$8.8M), CLDX, MRUS, Galecto, FDMT, KYTX, AVBP.
- Started 2 new stock positions in Zenas Biopharma, Galecto.
- Reduced shares in these 10 stocks: AAPL (-$39M), CRM (-$31M), PCVX (-$23M), EWTX (-$21M), BN (-$21M), MORF (-$13M), INSM (-$5.5M), LXEO, GLTO, IOBT.
- Sold out of its positions in AAPL, GLTO, MORF.
- Novo Holdings A/S was a net seller of stock by $-121M.
- Novo Holdings A/S has $2.0B in assets under management (AUM), dropping by 8.55%.
- Central Index Key (CIK): 0001388325
Tip: Access up to 7 years of quarterly data
Positions held by Novo A/S consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 37 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 14.6 | $294M | 1.0M | 283.16 |
|
|
| Tempus Ai Cl A (TEM) | 11.5 | $231M | 4.1M | 56.60 |
|
|
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 9.2 | $186M | -10% | 3.5M | 53.15 |
|
| Edgewise Therapeutics (EWTX) | 7.4 | $148M | -12% | 5.5M | 26.69 |
|
| Corcept Therapeutics Incorporated (CORT) | 5.5 | $112M | 2.4M | 46.28 |
|
|
| Asml Holding N V N Y Registry Shs (ASML) | 5.5 | $111M | 133k | 833.25 |
|
|
| salesforce (CRM) | 5.0 | $101M | -23% | 369k | 273.71 |
|
| Vaxcyte (PCVX) | 4.3 | $86M | -21% | 750k | 114.27 |
|
| Mirum Pharmaceuticals (MIRM) | 2.9 | $59M | 1.5M | 39.00 |
|
|
| Miragen Therapeutics (VRDN) | 2.7 | $54M | +19% | 2.4M | 22.75 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.6 | $53M | 501k | 106.12 |
|
|
| Insmed Com Par $.01 (INSM) | 2.6 | $53M | -9% | 725k | 73.00 |
|
| Crinetics Pharmaceuticals In (CRNX) | 2.5 | $51M | 1.0M | 51.10 |
|
|
| Cable One (CABO) | 2.1 | $41M | 118k | 349.79 |
|
|
| Arrivent Biopharma (AVBP) | 1.8 | $35M | 1.5M | 23.50 |
|
|
| Merus N V (MRUS) | 1.7 | $35M | +3% | 700k | 49.96 |
|
| BioMarin Pharmaceutical (BMRN) | 1.7 | $34M | 490k | 70.29 |
|
|
| Celldex Therapeutics Com New (CLDX) | 1.6 | $33M | +13% | 964k | 33.99 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $33M | 118k | 275.03 |
|
|
| Pharvaris N V (PHVS) | 1.6 | $32M | 1.7M | 18.52 |
|
|
| Lanzatech Global (LNZA) | 1.5 | $30M | 16M | 1.91 |
|
|
| Brookfield Asset Managmt Cl A Lmt Vtg Shs (BAM) | 1.5 | $30M | 627k | 47.29 |
|
|
| Cargo Therapeutics (CRGX) | 1.4 | $29M | 1.5M | 18.45 |
|
|
| Amicus Therapeutics (FOLD) | 1.3 | $27M | 2.5M | 10.68 |
|
|
| Rocket Pharmaceuticals (RCKT) | 1.0 | $20M | 1.1M | 18.47 |
|
|
| Zenas Biopharma | 1.0 | $20M | NEW | 1.2M | 16.92 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.8 | $16M | +7% | 1.5M | 10.81 |
|
| Blueprint Medicines (BPMC) | 0.8 | $16M | 175k | 92.50 |
|
|
| Verve Therapeutics (VERV) | 0.6 | $12M | 2.4M | 4.84 |
|
|
| Lexeo Therapeutics (LXEO) | 0.5 | $10M | -22% | 1.1M | 9.04 |
|
| Kyverna Therapeutics (KYTX) | 0.4 | $9.0M | +5% | 1.9M | 4.89 |
|
| Metagenomi (MGX) | 0.2 | $3.9M | 1.8M | 2.17 |
|
|
| Io Biotech (IOBT) | 0.2 | $3.5M | -24% | 3.4M | 1.05 |
|
| Abcellera Biologics (ABCL) | 0.1 | $2.9M | 1.1M | 2.60 |
|
|
| Marqeta Class A Com (MQ) | 0.1 | $2.2M | 442k | 4.92 |
|
|
| Galecto Com New | 0.1 | $1.2M | NEW | 100k | 12.15 |
|
| Spero Therapeutics (SPRO) | 0.0 | $628k | 469k | 1.34 |
|
Past Filings by Novo Holdings A/S
SEC 13F filings are viewable for Novo Holdings A/S going back to 2014
- Novo Holdings A/S 2024 Q3 filed Oct. 24, 2024
- Novo Holdings A/S 2024 Q2 restated filed Aug. 20, 2024
- Novo Holdings A/S 2024 Q1 filed May 15, 2024
- Novo Holdings A/S 2023 Q4 filed Feb. 14, 2024
- Novo Holdings A/S 2023 Q3 filed Nov. 14, 2023
- Novo Holdings A/S 2023 Q2 filed Aug. 14, 2023
- Novo Holdings A/S 2023 Q1 filed May 15, 2023
- Novo Holdings A/S 2022 Q4 filed Feb. 14, 2023
- Novo Holdings A/S 2022 Q3 filed Nov. 14, 2022
- Novo Holdings A/S 2022 Q2 filed Aug. 15, 2022
- Novo Holdings A/S 2022 Q1 restated filed May 27, 2022
- Novo Holdings A/S 2022 Q1 filed May 16, 2022
- Novo Holdings A/S 2021 Q4 filed Feb. 14, 2022
- Novo Holdings A/S 2021 Q3 filed Nov. 15, 2021
- Novo Holdings A/S 2021 Q2 filed Aug. 16, 2021
- Novo Holdings A/S 2021 Q1 filed May 17, 2021